Building on ideas presented by Erin O’Shea and colleagues (ASAPbio meeting, February 2018), once an editor has invited a paper for peer review, eLife is committed to publishing the work (https://elifesciences.org/inside-elife/2905802e/peer-review-elife-trials-a-new-approach). 1) New submissions were evaluated by Senior Editors to identify the papers to be invited for peer review. 2) After peer review and consultation between the reviewers, a Reviewing Editor compiles the feedback and peer reviews. 3) The authors decide how to respond, and submit a revision and their response to the reviews (unless they wish to withdraw their submission). 4) The Reviewing Editor evaluates the revised submission and responses, and the paper is published along with the decision letter, peer reviews, author responses, and an editorial rating (to indicate whether all issues had been addressed, or whether major or minor issues remain unresolved). The trial was closed once 300 authors had opted in.
Three main motivations:
Examples of data we hope to gather:
The gatekeeping role of peer review is removed. All peer-reviewed articles are published (unless the author chooses to withdraw their article).
The articles are labelled as Research Communications to indicate that they are part of the trial.
In “Peer Review: First results from a trial at eLife” (linked below), we compare the outcomes of 313 trial submissions with 665 regular submissions received during the same period of time. That is, almost a third of authors opted in to the trial approach. So far we have evaluated the first part of the editorial process (whether a paper is sent for in-depth review). The success rates at this first step for male and female last authors in the trial were similar (22.6% and 22.1% respectively), but late-career last authors fared better than their early- and mid-career colleagues. Further data will be posted and discussed covering the rest of the trial process.
Add a comment